WP
PJP icon

WealthShield Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

WealthShield Partners’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208 Buy
+2
New +$211 ﹤0.01% 605

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WealthShield Partners's PJP Position: Q1 2026 in Review

WealthShield Partners opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q1 2026: 2 shares worth $208. The stake represents ﹤0.01% of the portfolio and ranks #605 among its holdings.

119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • WealthShield Partners held 2 shares of Invesco Pharmaceuticals ETF worth $208 as of Q1 2026.
  • Invesco Pharmaceuticals ETF was a new WealthShield Partners position in Q1 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of WealthShield Partners's portfolio in Q1 2026, its #605 holding.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.